Compare the Efficacy and Safety of KH607 Tablets Versus Vortioxetine Hydrobromide Tablets in Adult Patients With Major Depressive Disorder
Clinical trial NCT07741331 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07741331
- Sponsor
- Chengdu Kanghong Pharmaceutical Group Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2027-12-01
- Enrollment
- 326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.